CareDx (CDNA) Tops Q4 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
CareDx (CNDA) PT, Estimates Cut at Piper Jaffray Post Q4
March 18, 2015 8:51 AM EDTPiper Jaffray analyst William R. Quirk lowered estimates and his price target on CareDx, Inc (NASDAQ: CDNA) to $8.00 (from $13.00) following Q4 results but maintained an Overweight rating.
Quirk commented, "CareDx reported 4Q14 revenue growth of 35.8% to $8.0M, above our ($6.7M) and consensus ($6.9M) expectations, although a... More
